HomeBUSINESS
BUSINESS

Micardis Generic Penetration “Faster than Expected”: Astellas President
(Nov.1.2017)

Astellas President Yoshihiko Hatanaka
Astellas Pharma has seen “faster-than-expected generic penetration” for its major hypertension drug Micardis (telmisartan), which faced generic debuts in June this year, President Yoshihiko Hatanaka said at an April-September earnings briefing ...
(LOG IN FOR FULL STORY)

News Calendar